Skip to main content

RETRACTION article

Front. Chem., 14 November 2023
Sec. Medicinal and Pharmaceutical Chemistry
Volume 11 - 2023 | https://doi.org/10.3389/fchem.2023.1332615
This article is part of the Research Topic Prostate Cancer: Molecular Entities Targeting This Challenging Disease View all 9 articles

Retraction: Design, synthesis, and biological evaluation of (E)-N’-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents

This article is a retraction of:

  1. RETRACTED: Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents

    1. Read original article
Frontiers Editorial Office Frontiers Editorial Office*

A Retraction of the Original Research Article
Design, synthesis, and biological evaluation of (E)-N’-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents

by Arjun HA, Elancheran R, Manikandan N, Lakshmithendral K, Ramanathan M, Bhattacharjee A, Lokanath NK and Kabilan S (2019). Front. Chem. 7:474. doi: 10.3389/fchem.2019.00474

The journal and Chief Editors retract the 10 July 2019 article cited above.

Following publication, concerns were raised regarding the integrity of some of the images in the article. After a corrigendum was published, additional concerns were identified, and a further investigation was conducted in line with Frontiers’ policies. The images were determined to have been manipulated, and the authors were unable to provide the raw data for the images in question. As a result, the data and conclusions of the article have been deemed unreliable and the article is therefore retracted.

The retraction of the article was approved by the Chief Editor of Frontiers in Chemistry and the Chief Executive Editor of Frontiers. The authors did not respond to the retraction.

Citation: Frontiers Editorial Office (2023) Retraction: Design, synthesis, and biological evaluation of (E)-N’-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents. Front. Chem. 11:1332615. doi: 10.3389/fchem.2023.1332615

Received: 03 November 2023; Accepted: 03 November 2023;
Published: 14 November 2023.

Approved by:

Steve Suib, University of Connecticut, United States

Copyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.